Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pinedo

Showing results (191-200 of 569) with videos related to

Pageof 57
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1992
The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278M Treskes, U Holwerda, L G Nijtmans, et al.
Cancer Immunology, Immunotherapy : CII|January 24, 1998
Construction and characterization of a fusion protein of single-chain anti-carcinoma antibody 323/A3 and human beta-glucuronidaseH J Haisma, R H Brakenhoff, I vd Meulen-Muileman, et al.
International Journal of Cancer|September 27, 2000
New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancerA H Van Hattum, H M Pinedo, H M Schlüper, et al.
Anticancer Research|July 1, 1992
In vitro chemosensitivity testing of multilayered microculturesP E Pizao, B Winograd, G J Peters, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
Effect of artificial electron acceptors on the cytotoxicity of mitomycin C and doxorubicin in human lung tumor cellsH G Keizer, S J De Leeuw, J Van Rijn, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 21, 1994
[Primary high-dose chemotherapy with hematopoietic growth factors followed by surgery and radiotherapy in stage III breast carcinoma; a Phase II study in 15 patients]K Hoekman, J Wagstaff, J B Vermorken, et al.
Journal of the National Cancer Institute|March 20, 1991
Clinical and pharmacologic study of orally administered uridineC J van Groeningen, G J Peters, J C Nadal, et al.
British Journal of Cancer|October 1, 1992
Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2J W Baars, J L Coenen, J Wagstaff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Prolonged neoadjuvant treatment in locally advanced tumours: a novel concept based on biological considerationsS A Luykx-de Bakker, H M Verheul, T D de Gruijl, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 13, 1992
Drug-transporter proteins in clinical multidrug resistanceR J Scheper, H J Broxterman, G L Scheffer, et al.
Pageof 57

Showing results (191-200 of 569) with videos related to

Sort By:
Pageof 57
Cancer Chemotherapy and Pharmacology|January 1, 1992
The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278M Treskes, U Holwerda, L G Nijtmans, et al.
Cancer Immunology, Immunotherapy : CII|January 24, 1998
Construction and characterization of a fusion protein of single-chain anti-carcinoma antibody 323/A3 and human beta-glucuronidaseH J Haisma, R H Brakenhoff, I vd Meulen-Muileman, et al.
International Journal of Cancer|September 27, 2000
New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancerA H Van Hattum, H M Pinedo, H M Schlüper, et al.
Anticancer Research|July 1, 1992
In vitro chemosensitivity testing of multilayered microculturesP E Pizao, B Winograd, G J Peters, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
Effect of artificial electron acceptors on the cytotoxicity of mitomycin C and doxorubicin in human lung tumor cellsH G Keizer, S J De Leeuw, J Van Rijn, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 21, 1994
[Primary high-dose chemotherapy with hematopoietic growth factors followed by surgery and radiotherapy in stage III breast carcinoma; a Phase II study in 15 patients]K Hoekman, J Wagstaff, J B Vermorken, et al.
Journal of the National Cancer Institute|March 20, 1991
Clinical and pharmacologic study of orally administered uridineC J van Groeningen, G J Peters, J C Nadal, et al.
British Journal of Cancer|October 1, 1992
Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2J W Baars, J L Coenen, J Wagstaff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Prolonged neoadjuvant treatment in locally advanced tumours: a novel concept based on biological considerationsS A Luykx-de Bakker, H M Verheul, T D de Gruijl, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 13, 1992
Drug-transporter proteins in clinical multidrug resistanceR J Scheper, H J Broxterman, G L Scheffer, et al.
Pageof 57